Zidovudine-Induced Anaemia in Human Immunodeficiency Virus Infected Children on Highly Active Anti-Retroviral Therapy in Jos, Nigeria
Journal Title: Journal of Advances in Medical and Pharmaceutical Sciences - Year 2014, Vol 1, Issue 1
Abstract
Aims: To determine the incidence and severity of zidovudine-induced anaemia in HIV-infected children initiated on anti-retroviral therapy in Jos, Nigeria. Study Design: This was an observational cohort study. Place and Duration of Study: AIDS Prevention Initiative in Nigeria (APIN)-supported HIV clinic of Jos University Teaching Hospital, Jos, Nigeria between April 2008 and March 2013. Methodology: We followed up HIV-infected children initiated on highly active anti-retroviral therapy (HAART) for 12 months. We compared the haemoglobin level at baseline, 3 months, 6 months and 12 months after initiation of HAART. We also compared the haemoglobin level of those on zidovudine (ZDV) and stavudine (d4T)-containing regimens. Results: Three hundred and fifty-two (92.1%) patients were on zidovudine-containing regimen while 30 (7.9%) were on stavudine-containing regimen. Three hundred and sixty-five (95.6%) were on cotrimoxazole while 17 (4.4%) were not on cotrimoxazole. The mean haemoglobin level at baseline was 10.8±2.1g/dl for the ZDV group and 6.9±1.3g/dl for the d4T group (P = .001). At baseline, 232 (60.7%) of the patients had anaemia while 26 (6.8%) had severe anaemia. At the end of the 12 months evaluation period, fifty-nine (16.8%) of the patients on ZDV had Hb <8g/dl and were switched to d4T while 16 (4.6%) received blood transfusion. The mean Hb level of ZDV group decreased from 10.8±2.1g/dl to 9.3±1.8g/dl (P = .03) while that of d4T group increased from 6.9±1.3g/dl to 11.2±1.5g/dl (P <.001). Conclusion: ZDV-induced anaemia was common in HIV-infected children on HAART in this study. Regular clinical and laboratory monitoring is necessary for early detection in order to mitigate the harmful effect anaemia has on the health and survival of such children.
Authors and Affiliations
Emeka U. Ejeliogu, Stephen Oguche, Augustine O. Ebonyi, Sylvanus E. Okpe, Esther S. Yiltok, Olukemi Ige, Martha O. Ochoga, Placid Ugoagwu, Christy Dady, Lucy Ogwuche, Oche O. Agbaji, Prosper Okonkwo
Analysis of O6-Methylguanine in Cancer Patient Blood during Administration of Cyclophosphamide Using Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry
Aims: To determine O6-Methylguanine in Cancer Patient Blood during Administration of Cyclophosphamide using Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry. Place and Duration of Study: Dharmais Can...
Induction of Heme Oxygenase-1 Improves Glucose Tolerance and Enhances Insulin Sensitivity in Obese Diabetic Rats
Aims: Obesity is a worldwide problem. It is considered to be a major risk factor for many systemic diseases like type 2 diabetes mellitus (T2D), cardiovascular, renal and orthopedic diseases. Recent evidence has undersco...
Effect of Aqueous Extract of Unripe Seeds of Carica papaya on Four Hematological Parameters of Salmonella-Induce Enteric Fever in Wistar Rats
Aims: The study evaluates the effect of aqueous extract of the seeds of unripe Carica papaya on the haematological parameters of Salmonella typhi-induced enteric fever in Wistar rats. Methodology: Enteric fever was induc...
H2O2-clearance Kinetics of Crude Catalase Preparations from Prostate Cancer Cell Lines Treated with Physiological and Synthetic Small Organic Ligands of PPAR-
Aim: To determine the differences in H2O2-clearance of two prostate cancer cell lines PC-3 and LNCaP treated with peroxisome proliferator-activated receptor gamma (PPAR-) ligands 15-deoxy- 12, 14 – prostaglandin J2 (PG...
Quality Control Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications
The therapeutically performance of the pharmaceuticals must be constant and expectable. In order to claim a pharmaceutical to be a quality drug, it must fulfill certain standards and specifications. The quality of pharm...